Both in Biotechnology
Elutia vs Metagenomi Therapeutics
Over the past year ELUT returned −16.8% and MGX returned −67.2%; their daily moves had a correlation of 0.11.
ELUT −16.8% MGX −67.2%Growth of $1, one year, split-adjusted
| Metric | ELUT | MGX |
|---|---|---|
| Price | $0.7781 | $0.7935 |
| Market cap | $34.5M | $30.0M |
| Today | −4.32% | +4.41% |
| 1 month | +0.2% | −23.0% |
| 6 months | −23.7% | −44.5% |
| Year to date | +12.3% | −51.0% |
| 1 year | −16.8% | −67.2% |
| Revenue growth (YoY) | −11.6% | −103.0% |
| Gross margin | 59.6% | — |
| Net margin | −315.0% | — |
| P/E (TTM) | 0.7× | — |
| Price / sales | 2.8× | 2.2× |
| Net cash | $19.9M | $120.7M |
| Dividend yield | — | — |
| Volatility (60d) | 61.4% | 48.0% |
| Short % of float | 0.0% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).